ALK-driven tumors and targeted therapy: focus on crizotinib

Carlos Murga-Zamalloa, Megan S Lim Department of Pathology, University of Michigan, Ann Arbor, MI, USA Abstract: Receptor tyrosine kinases have emerged as promising therapeutic targets for a diverse set of tumors. Overactivation of the tyrosine kinase anaplastic lymphoma kinase (ALK) has been report...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Principais autores: Murga-Zamalloa C (Autor), Lim MS (Autor)
Formato: Livro
Publicado em: Dove Medical Press, 2014-03-01T00:00:00Z.
Assuntos:
Acesso em linha:Connect to this object online.
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Internet

Connect to this object online.

3rd Floor Main Library

Detalhes do Exemplar 3rd Floor Main Library
Número de Chamada: A1234.567
Cópia 1 Disponível